Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nigel Leigh

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Plos One|September 21, 2011
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United KingdomPaul McCrone, Christine Anne Mary Payan, Martin Knapp, et al.
The Lancet. Neurology|March 12, 2018
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging studyTon Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 19, 2007
Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?Jeremy D Isaacs, Andrew F Dean, Christopher E Shaw, et al.
The Lancet. Neurology|June 20, 2018
Stage of prolonged survival in ALS - Author's replyAmmar Al-Chalabi, Ton Fang, Ahmad Al Khleifat, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 14, 2008
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET studyPaul Wicks, Martin R Turner, Sharon Abrahams, et al.
Neuroreport|September 17, 2004
A novel somatodendritic marker defined by a peptide derived from the ALS2 proteinVirginie Bros, Stephen J A Shemilt, Jonathan D Cooper, et al.
Brain : a Journal of Neurology|May 20, 2026
CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survivalJohanna K Vallikivi, Maarten Kooyman, , et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Nutritional management in MND/ALS patients: an evidence based reviewCatherine Heffernan, Crispin Jenkinson, Tricia Holmes, et al.
Archives of Neurology|June 10, 2009
Defining survival as an outcome measure in amyotrophic lateral sclerosisPaul H Gordon, Philippe Corcia, Lucette Lacomblez, et al.
Neurobiology of Aging|October 30, 2016
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratioMara Cercignani, Giovanni Giulietti, Nick G Dowell, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Plos One|September 21, 2011
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United KingdomPaul McCrone, Christine Anne Mary Payan, Martin Knapp, et al.
The Lancet. Neurology|March 12, 2018
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging studyTon Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 19, 2007
Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?Jeremy D Isaacs, Andrew F Dean, Christopher E Shaw, et al.
The Lancet. Neurology|June 20, 2018
Stage of prolonged survival in ALS - Author's replyAmmar Al-Chalabi, Ton Fang, Ahmad Al Khleifat, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 14, 2008
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET studyPaul Wicks, Martin R Turner, Sharon Abrahams, et al.
Neuroreport|September 17, 2004
A novel somatodendritic marker defined by a peptide derived from the ALS2 proteinVirginie Bros, Stephen J A Shemilt, Jonathan D Cooper, et al.
Brain : a Journal of Neurology|May 20, 2026
CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survivalJohanna K Vallikivi, Maarten Kooyman, , et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Nutritional management in MND/ALS patients: an evidence based reviewCatherine Heffernan, Crispin Jenkinson, Tricia Holmes, et al.
Archives of Neurology|June 10, 2009
Defining survival as an outcome measure in amyotrophic lateral sclerosisPaul H Gordon, Philippe Corcia, Lucette Lacomblez, et al.
Neurobiology of Aging|October 30, 2016
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratioMara Cercignani, Giovanni Giulietti, Nick G Dowell, et al.
Pageof 16